Search Results - "Daudi, Nili"

Hepatitis E in Israel: A nation-wide retrospective study by Erez-Granat, Ortal, Lachish, Tamar, Daudi, Nili, Shouval, Daniel, Schwartz, Eli

“…AIM: To investigate the epidemiology, risk factors and clinical course of acute hepatitis E virus(HEV) infection in Israel, an industrialized country.METHODS:…”
Get full text

Preclinical Evaluation of Two Human Anti–Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees by Eren, Rachel, Ilan, Ehud, Nussbaum, Ofer, Lubin, Ido, Terkieltaub, Dov, Arazi, Yossi, Ben-Moshe, Ofer, Kitchinzky, Alberto, Berr, Shoshana, Gopher, Judy, Zauberman, Arie, Galun, Eithan, Shouval, Danny, Daudi, Nili, Eid, Ahamed, Jurim, Oded, Magnius, Lars O., Hammas, Berit, Reisner, Yair, Dagan, Shlomo

“…Two human monoclonal antibodies (mAbs) against hepatitis B surface antigen (HBsAg) generated in the Trimera mouse system are described. Both mAbs 17.1.41 and…”
Get full text

Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries by Lachish, Tamar, Erez, Ortal, Daudi, Nili, Shouval, Daniel, Schwartz, Eli

“…Highlights • This is the first case series of acute HEV infection in pregnant women in industrialized countries. • In industrialized countries, acute HEV…”
Get full text

Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups by Manor, Yosef, Lewis, Matthew, Ram, Daniela, Daudi, Nili, Mor, Orna, Savion, Michal, Kra-Oz, Zipi, Avni, Yonat Shemer, Sheffer, Rivka, Shouval, Daniel, Mendelson, Ella

“…Background. Hepatitis A virus (HAV) molecular epidemiology in Israel was studied 13–14 years after introduction of universal toddler vaccination (UTV), which…”
Get full text

Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groups by Manor, Yosef, Lewis, Matthew, Ram, Daniela, Daudi, Nili, Mor, Orna, Savion, Michal, Kra-Oz, Zipi, Shemer Avni, Yonat, Sheffer, Rivka, Shouval, Daniel, Mendelson, Ella

“…Universal toddlers vaccination (UTV) introduced in 1999, reduced hepatitis A incidence in Israel from 50.4 to <1.0/100,000. The current Hepatitis A virus (HAV)…”
Get full text

Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection by Daudi, Nili, Shouval, Daniel, Stein-Zamir, Chen, Ackerman, Zvi

“…Breastmilk specimens from three women with acute hepatitis A virus (HAV) infection were studied. Anti-HAV immunoglobulin M and immunoglobulin G antibodies were…”
Get more information

Femtosecond laser: a new intradermal DNA delivery method for efficient, long-term gene expression and genetic immunization by Zeira, Evelyne, Manevitch, Alexandra, Manevitch, Zakharia, Kedar, Eli, Gropp, Michal, Daudi, Nili, Barsuk, Rimma, Harati, Menahem, Yotvat, Hagit, Troilo, Philip J, Griffiths, Thomas G. II, Pacchione, Stephen J, Roden, Dana F, Niu, Zhutian, Nussbaum, Ofer, Zamir, Gideon, Papo, Orit, Hemo, Izhack, Lewis, Aaron, Galun, Eithan

“…A femtosecond laser beam gene transduction (SG-LBGT) system is described as a novel and efficient method of intradermal (i.d.) nonviral gene delivery in mice…”
Get full text

The Hepatitis C Virus (HCV)–Trimera Mouse: A Model for Evaluation of Agents against HCV by Ilan, Ehud, Arazi, Joseph, Nussbaum, Ofer, Zauberman, Arie, Eren, Rachel, Lubin, Ido, Neville, Lewis, Ben-Moshe, Ofer, Kischitzky, Alberto, Litchi, Amir, Margalit, Ido, Gopher, Judith, Mounir, Samir, Cai, Weizhong, Daudi, Nili, Eid, Ahamed, Jurim, Oded, Czerniak, Abraham, Galun, Eithan, Dagan, Shlomo

“…The lack of small-animal models that are suitable for evaluation of agents used to treat infection with hepatitis C virus (HCV) severely hinders the assessment…”
Get full text

Genotypic and Phenotypic Resistance: Longitudinal and Sequential Analysis of Hepatitis B Virus Polymerase Mutations in Patients With Lamivudine Resistance After Liver Transplantation by Ben-Ari, Ziv, Daudi, Nili, Klein, Athalia, Sulkes, Jaqueline, Papo, Orit, Mor, Eytan, Samra, Zmira, Gadba, Rachamim, Shouval, Daniel, Tur-Kaspa, Ran

“…Lamivudine-resistant strains appear in 27–62.5% of liver transplant recipients treated with lamivudine for hepatitis B virus (HBV) recurrence, and may lead to…”
Get full text

Relationship between hepatitis B virus (HBV) genotype and the precore mutant in anti-HBe(+) patients before and after liver transplantation (LT) by Ben-Ari, Ziv, Ashur, Yaffa, Daudi, Nili, Wiess, Hemda, Sulkes, Jaqueline

Get full text

Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation by Ben-Ari, Ziv, Ashur, Yaffa, Daudi, Nili, Shmilovitz-Wiess, Hemda, Brown, Marius, Sulkes, Jaqueline, Klein, Athalia, Mor, Eytan, Tur-Kaspa, Ran, Shouval, Daniel

“…:  Objective:  The precore mutant is detectable in most Israeli patients with persistent hepatitis B virus (HBV) infection. The aim of this study was to…”
Get full text

Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen‐specific antibodies in the Trimera mouse by Böcher, Wulf Otto, Galun, Eithan, Marcus, Hadar, Daudi, Nili, Terkieltaub, Dov, Shouval, Daniel, Löhr, Hanns Friedrich, Reisner, Yair

“…In chronic hepatitis B virus (HBV) infection weak antiviral immune responses are associated with viral persistence. We studied possible immune deficits…”
Get full text

Human Interleukin-6 Facilitates Hepatitis B Virus Infection in Vitro and in Vivo by Galun, Eithan, Nahor, Orit, Eid, Ahmed, Jurim, Oded, Rose-John, Stefan, Blum, Hubert E., Nussbaum, Ofer, Ilan, Ehud, Daudi, Nili, Shouval, Daniel, Reisner, Yair, Dagan, Shlomo

“…Background and aim. Research on hepatitis B virus (HBV) infection in vivo has been limited due to the absence of a suitable animal model. We have developed a…”
Get full text

Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation by Ben-Ari, Ziv, Daudi, Nili, Klein, Athalia, Sulkes, Jaqueline, Papo, Orit, Mor, Eytan, Samra, Zmira, Gadba, Rachamim, Shouval, Daniel, Tur-Kaspa, Ran

“…Lamivudine-resistant strains appear in 27–62.5% of liver transplant recipients treated with lamivudine for hepatitis B virus (HBV) recurrence, and may lead to…”
Get full text